SOLID ASSURE PLUS

Primær information

  • Handelsnavn:
  • SOLID ASSURE PLUS
  • Brugt til:
  • Mennesker
  • Medicin typen:
  • Medicinsk udstyr

Dokumenter

  • for den brede offentlighed:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for offentligheden.

  • for sundhedspersonale:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for sundhedspersonale.

Lokation

  • Fås i:
  • SOLID ASSURE PLUS
    Danmark
  • Sprog:
  • dansk

Andre oplysninger

Status

  • Kilde:
  • Ecolab
  • Autorisationsnummer:
  • 110753E
  • Sidste ændring:
  • 12-03-2018
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.

    Anmode informationsbrochure for offentligheden.



  • Dokumenter på andre sprog er tilgængelige her

17-4-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to enhance and modernize the FDA’s approach to medical device safety and innovation

Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to enhance and modernize the FDA’s approach to medical device safety and innovation

The FDA is releasing the Medical Device Safety Action Plan that outlines our vision for how FDA can continue to enhance our programs and processes to assure the safety of medical devices

FDA - U.S. Food and Drug Administration

8-3-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on effort to help bolster U.S. shellfish market by taking mutually beneficial steps to resume shellfish trade with the EU

Statement from FDA Commissioner Scott Gottlieb, M.D., on effort to help bolster U.S. shellfish market by taking mutually beneficial steps to resume shellfish trade with the EU

FDA announces proposed shellfish equivalence determination with the EU that will create new market access for U.S. exporters as well as make a wider selection of healthy and safe shellfish options available to consumers. It will also assure American consumers that imported molluscan shellfish from Europe is as safe as what we produce in the U.S.

FDA - U.S. Food and Drug Administration

17-7-2017

Orphan designation:  Murine IgM monoclonal antibody binding to alpha beta T-cell receptor,  for the: Prevention of graft rejection following solid organ transplantation

Orphan designation: Murine IgM monoclonal antibody binding to alpha beta T-cell receptor, for the: Prevention of graft rejection following solid organ transplantation

On 12 March 2013, orphan designation (EU/3/13/1113) was granted by the European Commission to CTI Clinical Trial and Consulting Services, Germany, for murine IgM monoclonal antibody binding to alpha beta T-cell receptor for the prevention of graft rejection following solid organ transplantation.

Europe - EMA - European Medicines Agency

3-7-2017

FDA clears expanded use of cooling cap to reduce hair loss during chemotherapy

FDA clears expanded use of cooling cap to reduce hair loss during chemotherapy

Today, the U.S. Food and Drug Administration cleared the expanded use of a cooling cap, DigniCap Cooling System, to reduce hair loss (alopecia) during chemotherapy. This is the first cooling cap cleared by the agency for use in cancer patients with solid tumors.

FDA - U.S. Food and Drug Administration

23-5-2017

FDA approves first cancer treatment for any solid tumor with a specific genetic feature

FDA approves first cancer treatment for any solid tumor with a specific genetic feature

The U.S. Food and Drug Administration today granted accelerated approval to a treatment for patients whose cancers have a specific genetic feature (biomarker). This is the first time the agency has approved a cancer treatment based on a common biomarker rather than the location in the body where the tumor originated

FDA - U.S. Food and Drug Administration

5-1-2018

Most U.S. Babies Start Solid Foods Too Soon

Most U.S. Babies Start Solid Foods Too Soon

Title: Most U.S. Babies Start Solid Foods Too SoonCategory: Health NewsCreated: 1/4/2018 12:00:00 AMLast Editorial Review: 1/4/2018 12:00:00 AM

US - MedicineNet

28-12-2017

CERTAIN DRI SOLID (Aluminum Sesquichlorohydrate) Stick [Clarion Brands, LLC]

CERTAIN DRI SOLID (Aluminum Sesquichlorohydrate) Stick [Clarion Brands, LLC]

Updated Date: Dec 28, 2017 EST

US - DailyMed

31-10-2017

Scientific guideline:  Concept paper on the development of a reflection paper on new analytical methods/technologies in the quality control of herbal medicinal products, draft: consultation open

Scientific guideline: Concept paper on the development of a reflection paper on new analytical methods/technologies in the quality control of herbal medicinal products, draft: consultation open

Quality control is a prerequisite to assure safe and effective use of (traditional) herbal medicinal products, which are complex mixtures of numerous phytochemical constituents. For the majority of herbal substances, herbal preparations and (traditional) herbal medicinal products the active constituents are not known or are only partly understood.

Europe - EMA - European Medicines Agency

3-7-2017

FDA Expands Use of Cooling Cap to Reduce Hair Loss During Chemotherapy

FDA Expands Use of Cooling Cap to Reduce Hair Loss During Chemotherapy

Today, the U.S. Food and Drug Administration cleared the expanded use of a cooling cap, DigniCap Cooling System, to reduce hair loss (alopecia) during chemotherapy. This is the first cooling cap cleared by the agency for use in cancer patients with solid tumors.

US - RxList